The AstraZeneca PLC ADR
slid 2.49% to $49.31 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average
rising 0.05% to 31,537.35 and the NASDAQ Composite Index
falling 0.50% to 13,465.20. This was the ADR’s third consecutive day of losses. AstraZeneca PLC ADR closed $15.63 below its 52-week high ($64.94), which the company achieved on July 20th.
The ADR underperformed when compared to some of its competitors Tuesday, as AbbVie Inc.
fell 0.74% to $106.27, Amgen Inc.
rose 0.43% to $232.46, and Gilead Sciences Inc.
fell 0.67% to $63.68. Trading volume (14.5 M) eclipsed its 50-day average volume of 12.7 M.